drugset / Trial / NCT00117481

Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain

NCT00117481 ↗

Phase 2 Completed 90 enrolled Duramed Research
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a 3-arm, multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy of DR-2001 in endometriosis-related symptoms, primarily nonmenstrual pelvic pain, over a 12-week treatment period.

Timeline

Start
2005-06
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject DR-2001a Unknown — Other
Subject DR-2001b Unknown — Other

Indications